Placenta accreta and methotrexate therapy: Three case reports

被引：58

作者：

Mussalli G.M. ^{[1
,3
]}

Shah J. ^{[2
]}

Berck D.J. ^{[1
]}

Elimian A. ^{[2
]}

Tejani N. ^{[2
]}

Manning F.A. ^{[2
]}

机构：

[1] Dept. of Obstetrics and Gynecology, Columbia University, College of Physicians and Surgeons, New York, NY

[2] Dept. of Obstetrics and Gynecology, New York Medical College, Valhalla, NY

[3] Dept. of Obstetrics and Gynecology, Jacobi Medical Center, Bronx, NY 10461

来源：

Journal of Perinatology | 2000年 / 20卷 / 5期

关键词：

D O I：

10.1038/sj.jp.7200373

中图分类号：

学科分类号：

摘要：

Placenta accreta is a complication that is rising in incidence. The reported experience of methotrexate treatment in the conservative management of placenta accreta is scant. Three cases of placenta accreta managed with methotrexate are presented. Case 1: A woman had an antenatal diagnosis of placenta percreta. A successful manual placental removal occurred on post-cesarean day 16. Case 2: A woman had retention of a placenta accreta after a term vaginal delivery. Successful dilation and curettage were performed on postpartum day 37. Case 3: A woman had an antenatal diagnosis of placenta previa-percreta with bladder invasion. A simple hysterectomy was performed on post-cesarean day 46. Conservative management and methotrexate treatment resulted in uterine preservation in two of our three patients; however, this treatment did not prevent significant delayed hemorrhage. In view of the rapid resolution of vascular invasion of the bladder, methotrexate may have an important role in the management of placenta percreta with bladder invasion. The utility of methotrexate treatment with the conservative management of placenta accreta requires further evaluation.

引用

页码：331 / 334

页数：3

共 16 条

[1]

Eltabbakh G.H., Watson J.D., Postpartum hysterectomy, Int J Gynecol Obstet, 50, pp. 257-262, (1995)

[2]

Leaphart W.L., Schapiro U., Broome J., Welander C.E., Bernstein I.M., Placenta previa percreta with bladder invasion, Obstet Gynecol, 89, pp. 834-835, (1997)

[3]

Arulkumaran S., Ng C.S., Ingemarsson I., Ratnam S.S., Medical treatment of placenta accreta with methotrexate, Acta Obstet Gynecol Scand, 65, pp. 285-286, (1986)

[4]

Raziel A., Golan A., Ariely S., Herman A., Caspi E., Repeated ultrasonography and intramuscular methotrexate in the conservative management of residual adherent placenta, J Clin Ultrasound, 20, pp. 288-290, (1992)

[5]

Bakri Y.N., Rifai A., Legarth J., Placenta previa-percreta: Magnetic resonance imaging findings and methotrexate therapy after hysterectomy, Am J Obstet Gynecol, 169, pp. 213-214, (1993)

[6]

Legro R.S., Price F.V., Hill L.M., Caritis S.N., Nonsurgical management of placenta percreta: A case report, Obstet Gynecol, 83, pp. 847-849, (1994)

[7]

Jaffe R., DuBeshter B., Sherer D.M., Thompson E.A., Woods J.R., Failure of methotrexate treatment for term placenta percreta, Am J Obstet Gynecol, 171, pp. 558-559, (1994)

[8]

Buckshee K., Dadhwal V., Medical management of placenta accreta, Int J Gynecol Obstet, 59, pp. 47-48, (1997)

[9]

Gupta D., Sinha R., Management of placenta accreta with oral methotrexate, Int J Gynecol Obstet, 60, pp. 171-173, (1997)

[10]

Gibb D.M., Soothill P.W., Ward K.J., Conservative management of placenta accreta, Br J Obstet Gynecol, 101, pp. 79-80, (1994)

← 1 2 →